QELBREE 100 mg/1 (Viloxazine Hydrochloride CAPSULE, EXTENDED RELEASE) 100 mg/1

QELBREE 100 mg extended-release capsules contain viloxazine hydrochloride, a medication used to manage certain mental health conditions. This extended-release formulation is designed to provide consistent levels of the active ingredient over time.

Strength

100 mg/1

Pack Size

30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-30)

Manufacturer / TM Owner

Supernus Pharmaceuticals, Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

QELBREE is primarily used to address symptoms associated with specific mental health conditions. It is often prescribed to help manage attention deficit hyperactivity disorder (ADHD) in adults. The medication works by affecting certain chemicals in the brain that may be unbalanced in individuals with ADHD. QELBREE is not typically used for immediate relief but rather for long-term management of symptoms.

Side Effects

Common effects of QELBREE may include changes in appetite, sleep disturbances, and mild gastrointestinal discomfort. Some individuals may experience dizziness or headaches, especially when first starting the medication. These effects are generally mild and may diminish as the body adjusts to the medication.

Precautions & Warnings

QELBREE should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Do not crush or chew the extended-release capsules, as this can affect the release of the medication. Always consult a healthcare provider before starting or stopping any medication.

Avoid Interactions

QELBREE may interact with certain medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol should be avoided while taking QELBREE, as it may increase the risk of side effects.

Frequently Asked Questions

QELBREE is used to manage symptoms of attention deficit hyperactivity disorder (ADHD) in adults.

QELBREE should be taken orally, preferably with food, and the capsules should not be crushed or chewed.

Common side effects may include changes in appetite, sleep disturbances, and mild gastrointestinal discomfort.

It is important to consult a healthcare provider before taking QELBREE with other medications, as interactions may occur.

QELBREE is designed for long-term management of symptoms, but regular follow-ups with a healthcare provider are recommended.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.